tool name

close
tool goes here

Kodak backs away from patent auction

Kodak is postponing indefinitely an auction of its imaging patent portfolios.

Published: Sept. 15, 2012 at 12:05 a.m. PDT
0 comments

Kodak is postponing indefinitely an auction of its imaging patent portfolios.

An auction hearing had been scheduled in August for Eastman Kodak Co. to sell more than 1,000 patents as it tries to emerge from bankruptcy protection. The auction kept getting postponed as talks with potential buyers continued.

In a court filing Friday, Kodak said it won’t keep rescheduling, even as negotiations continue. It also said it is “continuing to explore other alternatives,” which include keeping the patents. Kodak previously disclosed the option of keeping its patents, but Friday’s filing added the possibility of creating a company to make money by licensing the technology.

JOIN THE DISCUSSION | Register here

We welcome comments. Please keep them civil, short and to the point. ALL CAPS, spam, obscene, profane, abusive and off topic comments will be deleted. Repeat offenders will be blocked. Thanks for taking part — and abiding by these simple rules. A thorough explanation of rules of conduct can be found in our Terms of Service. If you have any questions, including why your comment may not be showing immediately after you submit it, be sure to visit the commenting FAQ.

CONTESTS

Similar stories

  • Rob McKenna still filing consumer protection actions in final days on the AG job (Politics Blog)

    Washington Attorney General Rob McKenna has just a few days left in office, but he and his people are still keeping busy. On Friday, Jan. 11, McKenna announced a legal settlement with an online "penny auction" company that was accused of using "bidbots" to inflate auction prices.

    Read more on the Politics Blog: Click here

  • High court rules for Monsanto in patent case

    The Supreme Court said Monday that an Indiana farmer violated Monsanto Co.'s patents on soybean seeds resistant to its weed-killer by growing the beans without buying new seeds from the corporation.

  • RIM plans for service fees halts stock rally

    Research In Motion’s decision to scrap service fees for some users is threatening its most profitable source of revenue and bringing its three-month stock rally to a halt.

  • India’s top court rejects patent case by drug maker

    India’s Supreme Court on Monday rejected drug maker Novartis AG’s attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.

  • Apple/Samsung judge cuts $450M from $1 billion award

    A San Jose federal judge on Friday slashed about $450 million from the $1 billion a jury awarded Apple in August in its patent feud with Samsung, the latest in a series of decisions weakening Apple’s legal assault on its smartphone and tablet rival.